Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT04584294
Eligibility Criteria:
Inclusion Criteria:
Patients:
* Female sex identified in medical record
* 18 - 44 years old
* Has a scheduled VA medical appointment with an enrolled study provider
* Has at least one valid telephone number available in medical record
* Interested in receiving information or talking with their provider about pregnancy and/or birth control
Providers:
* Primary Care Provider (MD, Nurse Practitioner, Physician Assistant) at a study site
* Designated as a Women's Health Provider \[defined in VA directive 1330.01 as primary care providers who have demonstrated proficiency (e.g. pelvic exams and pap smears) in women's health and who have at least 10% of their panel comprised of women\]
* Completed appointments with at least 30 unique female patients ages 18-44 in the past year at a study site
Exclusion Criteria:
Patients:
* Currently pregnant
* Medical record or self-reported history of hysterectomy, bilateral oophorectomy; or self-report of not having a uterus
* Unable to communicate in English
* Impaired decision-making
* Used the decision tool prior to study enrollment (e.g. during pilot testing of the tool)
Providers:
* Previous involvement as a provider in MyPath pilot work (identified by the PI)
* Medical trainee
* Self-report that they have plans to leave VA, go on extended leave, retire, stop primary care practice, or change VA site in the 18 months following their enrollment
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
44 Years
Study:
NCT04584294
Study Brief:
Protocol Section:
NCT04584294